ArticleJournal of thrombosis and haemostasis : JTH2022

Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab.

Eva Laverdure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.